Regulatory Filings • Oct 16, 2014
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 16 October 2014 10:49
Carl Zeiss Meditec in advanced negotiations with Abbott Medical Optics Inc. about US commercial collaboration agreement in the field of cataract surgery
Carl Zeiss Meditec AG / Key word(s): Alliance
16.10.2014 10:49
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Carl Zeiss Meditec in advanced negotiations with Abbott Medical Optics Inc.
about US commercial collaboration agreement in the field of cataract
surgery
Jena, 16 October 2014: Carl Zeiss Meditec AG (ISIN: DE0005313704) is in
advanced negotiations about a US commercial collaboration agreement with
Abbott Medical Optics Inc. (AMO), Santa Ana, USA in the field of cataract
surgery. Closing of the collaboration agreement is expected shortly.
The aim of the collaboration is to establish a new distribution channel for
ZEISS devices for cataract surgery in addition to the existing ZEISS sales
channel.
The intended agreement shall be non-exclusive and limited to the US market.
Contact for investors
Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG
Tel. +49 3641 220-116, E-Mail: [email protected]
Press contact
Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss
Meditec AG
Tel. +49 3641 220-331, E-Mail: [email protected]
16.10.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: [email protected],[email protected]
Internet: www.meditec.zeiss.de
ISIN: DE0005313704
WKN: 531370
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart
End of Announcement DGAP News-Service
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.